Research location
Chieri
Italy
Advertisement
Research activity in Chieri
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 14 trials and 14 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Chieri
14 linked trials · page 1 of 1Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal MedicineNCT07727070 · 2025-12-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 DiabetesNCT05901831 · 2024-02-26 · 1 site observation
COMPLETED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)NCT01147250 · 2010-06-01 · 1 site observation
COMPLETED
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 DiabetesNCT01060059 · 2010-04-01 · 1 site observation
COMPLETED
The Clinical Evaluation of the Dose of Erythropoietins TrialNCT00827021 · 2009-07-01 · 1 site observation
COMPLETED
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 DiabetesNCT00860288 · 2009-02-01 · 1 site observation
COMPLETED
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentNCT00663260 · 2008-06-01 · 1 site observation
COMPLETED
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00331851 · 2006-05-01 · 1 site observation
COMPLETED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesNCT00252876 · 2005-03-01 · 1 site observation
TERMINATED
GALLANT 4 Tesaglitazar vs. GlibenclamideNCT00255541 · 2004-09-01 · 1 site observation
TERMINATED
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaNCT00095290 · 2004-09-01 · 1 site observation
COMPLETED
GALLANT 8 Tesaglitazar Add-on to MetforminNCT00251953 · 2004-07-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.